Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: J Affect Disord. 2019 Jul 2;257:17–22. doi: 10.1016/j.jad.2019.06.050

Table 1.

Characteristics of study population for those with vs. without complex polypharmacy (CP) for the majority of study

All (N=482) Col % Non-CP (N=360) Col % CPa (N=122) Col % P-value
Age: <25 14% 16% 8% 0.055
 25–35 27% 28% 23%
 35–45 23% 20% 30%
 45–55 26% 26% 27%
 55+ 10% 10% 12%
Sex: Female 59% 58% 62% 0.353
Race: White 72% 70% 80% 0.073
 Black 21% 24% 14%
 Other 7% 7% 7%
Education: High School/GED or less 25% 27% 20% 0.157
Employment: Employed or studentb 45% 49% 34% 0.005*
Current diagnosis: BD I (vs. BD II) 68% 66% 74% 0.131
Social or generalized anxiety disorder 39% 37% 48% 0.034*
Lifetime history of substance use disorder 45% 44% 45% 0.903
Lifetime history of psychiatric hospitalization 47% 45% 53% 0.120
Lifetime history of suicide attempt 39% 38% 41% 0.561
Randomized to lithium + APT 50% 48% 56% 0.129
 Quetiapine + APT 50% 52% 44%
Improvement in CGI-BP-S score ≥1 77% 79% 70% 0.055
Remission (CGI-BP-S score ≤2 for 8+ weeks) 22% 24% 16% 0.042

Mean (SD) Mean (SD) Mean (SD)

Age 38.9 (12.1) 38.1 (12.3) 41.3 (11.4) 0.010*
Baseline CGI-BP-S (overall, out of 7) 4.5 (0.9) 4.5 (0.9) 4.6 (0.8) 0.125
Baseline BISS depression score (0/88) 37.5 (14.0) 36.7 (14.2) 39.8 (13.5) 0.035*
Baseline BISS mania score (0/92) 19.1 (12.2) 19.6 (12.6) 17.7 (10.7) 0.137
Mean number of BD medications 2.0 (1.0) 1.5 (0.5) 3.4 (0.7) <.001*
*

p<0.05 for unadjusted difference between CP and non-CP in two-sided test statistic.

a

Complex polypharmacy was defined as being prescribed ≥3 bipolar drugs for greater than 50% of study visits.

b

Employment is defined as employed or student status, while unemployed includes those who are retired, on disability, and other.

Abbreviations: CP = Complex Polypharmacy, BD = Bipolar Disorder, APT = Adjunctive Personalized Therapy, CGI-BP-S = Clinical Global Impressions – Bipolar Scale